(information valid as of 10 December 2024) Tair Kulteleev Partner, Senior Associate www.aequitas.kz We continue a series of publications covering legal aspects of activities in the Astana International Financial Centre…
(information is valid as of 2 October 2024) Yekaterina Khamidullina AEQUITAS Partner Director of AEQUITAS AIFC Branch Tair Kulteleev Head of Registrations Senior Associate www.aequitas.kz This publication offers our answers…
Yekaterina Khamidullina AEQUITAS Partner Director of AEQUITAS AIFC Branch Tair Kulteleev Head of Registrations, Senior Associate www.aequitas.kz We continue a series of publications relating to the legal aspects of activities…
Tair Kulteleev Head of Registrations, Senior Associate AEQUITAS Law Firmwww.aequitas.kz Once a company has been set up, obtained a license and commenced carrying out its activities, it will inevitably encounter…
Tair Kulteleev Head of Registrations Senior AssociateAEQUITAS Law Firm www.aequitas.kz Amid the geopolitical tension in the region and consequences of the anti-Russian sanctions, offices of many western companies have already…
The interest of investors in the Republic of Kazakhstan (the "Kazakhstan") and the Astana International Financial Centre (the "AIFC") has been growing steadily. This has become especially noticeable during the…
Yekaterina Khamidullina, Partner, Director of AEQUITAS AIFC Branch Emin Nadirov, Junior Associate AEQUITAS Law Firm The Astana International Financial Centre (the "AIFC") offers companies a unique opportunity to work in…
Today’s China wants to empower common development with rule-of-law and usher in the future with innovation and sharing. Focusing on the “two overall situations”, General Secretary Xi Jinping promotes the…
Магистр права, менеджер по вопросам политики здравоохранения и доступа на рынок Рош Диагностика Центральная Азия и Кавказ. Специализация: государственная политика и связи с общественностью, регуляторные вопросы, право интеллектуальной собственности. Shynggys…
Introduction Pharmaceutical companies are consistently developing advanced products designed to diagnose and treat patients worldwide. When a new solution is initially introduced to the market in the country of origin…